Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $0.70, in-line with the analyst estimate of $0.70. Revenue for the quarter came in at $4.68 billion versus the consensus estimate of $4.78 billion.

Eli Lilly & Co. sees FY2014 adjusted EPS of $2.72 - $2.80, versus the consensus of $2.81.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.